Cardlytics (CDLX) intends to raise $75 million in a U.S. IPO by selling 5.4 million shares of its common stock at a midpoint price of $14.00 per share.

The firm has developed software that helps marketers analyze prospective customer behavior via historical purchase data and analytics.

CDLX is attempting a strategic transition, but management hasn’t described where it intends to transition, a time frame or any other details.

READ FULL ARTICLE HERE